Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hospital Mater DeiBSP:MATD3 +1.45%85 Debt-to-Equity is 1.44 as of Mar. 2026, which is 13% above its 10-year median of 1.27. GuruFocus rates BSP:MATD3 with a GF Score™ of 85/100 and a GF Value™ of R$5.89 (Modestly Undervalued). The stock has 3 warning signs investors should review. Among 556 Healthcare Providers & Services companies, Hospital Mater Dei ranks worse than 82.91% on this metric.
A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.
The historical rank and industry rank for Hospital Mater Dei's Debt-to-Equity or its related term are showing as below:
BSP:MATD3'
s Debt-to-Equity Range Over the Past 10 Years
Min: 0.2 Med: 1.27 Max: 2.46
Current: 1.44
During the past 9 years, the highest Debt-to-Equity Ratio of Hospital Mater Dei was 2.46. The lowest was 0.20. And the median was 1.27.
BSP:MATD3's Debt-to-Equity is ranked worse than 82.91% of 556
companies
in the Healthcare Providers & Services industry
Industry Median: 0.4
vs BSP:MATD3: 1.44
Hospital Mater Dei (BSP:MATD3) Debt-to-Equity Explanation
Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.
Hospital Mater Dei Debt-to-Equity Related Terms
Hospital Mater Dei Debt-to-Equity Historical Data
* Premium members only.
The historical data trend for Hospital Mater Dei's Debt-to-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BSP:MATD3 vs HCA, THC, DVA: Debt-to-Equity Comparison
For the Medical Care Facilities subindustry, Hospital Mater Dei's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hospital Mater Dei Debt-to-Equity vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Hospital Mater Dei's Debt-to-Equity distribution charts can be found below:
* The bar in red indicates where Hospital Mater Dei's Debt-to-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hospital Mater Dei (BSP:MATD3) has a Debt-to-Equity of 1.44 as of Mar. 2026. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Hospital Mater Dei and its competitors. This is 13% above median its historical median of 1.27. Over the past decade, Hospital Mater Dei's Debt-to-Equity has ranged from 0.20 to 2.46. According to the industry distribution chart, Hospital Mater Dei ranks #461 out of 556 companies in the Healthcare Providers & Services industry, placing it in the top 82.9%.
Is Hospital Mater Dei's Debt-to-Equity too high?
Hospital Mater Dei's current Debt-to-Equity of 1.44 is 13% above median its 10-year median of 1.27. Over the past 10 years, this metric has ranged from a low of 0.20 to a high of 2.46. The Healthcare Providers & Services industry median Debt-to-Equity is 0.40. Hospital Mater Dei's value of 1.44 is 260% above this industry median. Based on the distribution chart, Hospital Mater Dei ranks #461 out of 556 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Hospital Mater Dei has a GF Score™ of 85/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Hospital Mater Dei's Debt-to-Equity compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Hospital Mater Dei ranks #461 out of 556 companies for Debt-to-Equity. This places Hospital Mater Dei in the lower half of its industry. The industry median Debt-to-Equity is 0.40. Hospital Mater Dei's value of 1.44 is 260% above this benchmark. Historically, Hospital Mater Dei's own Debt-to-Equity has ranged from 0.20 to 2.46 over the past decade. While the company's 10-year median is 1.27 vs. the industry median of 0.40, Hospital Mater Dei has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Debt-to-Equity for a Healthcare Providers & Services company?
The median Debt-to-Equity among Healthcare Providers & Services companies is 0.40, based on 556 companies in the industry. Companies in the top quartile (top 25%) have a Debt-to-Equity significantly above this median, while those in the bottom quartile fall well below. However, Debt-to-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hospital Mater Dei's current Debt-to-Equity of 1.44 is 260% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Debt-to-Equity mean?
A high Debt-to-Equity can signal that a stock is expensive relative to its fundamentals. Debt-to-Equity ratio represents the ratio of total debt to total company equity. View historical data on Hospital Mater Dei and its competitors. For the Healthcare Providers & Services industry, the median Debt-to-Equity is 0.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hospital Mater Dei's current Debt-to-Equity is 1.44, which is 13% above median its own 10-year median of 1.27. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hospital Mater Dei stock overvalued right now?
Based on GuruFocus' analysis, Hospital Mater Dei (BSP:MATD3) is currently considered Modestly Undervalued. The stock's GF Value™ is R$5.89, compared to a current price of R$4.91 — trading 16.6% below its estimated fair value. The current Debt-to-Equity is 1.44, which is 13% above median its 10-year median of 1.27 and 260% above the Healthcare Providers & Services industry median of 0.40. Hospital Mater Dei's overall GF Score™ is 85/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Debt-to-Equity calculated?
Debt-to-Equity is calculated from a company's financial statements. For Hospital Mater Dei (BSP:MATD3), the current Debt-to-Equity is 1.44 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hospital Mater Dei (BSP:MATD3) Overvalued in 2026?
Based on GuruFocus' analysis, Hospital Mater Dei stock appears to be undervalued.
The current stock price of R$4.91 is trading 16.6% below its estimated GF Value™ of R$5.89.
GuruFocus considers Hospital Mater Dei to be Modestly Undervalued.
Key valuation signals for BSP:MATD3:
Debt-to-Equity: 1.44 (13% above median its 10-year median of 1.27)
GF Value™: R$5.89 vs. price of R$4.91 (16.6% below fair value)
Industry Position: 260% above the Healthcare Providers & Services median (#461 of 556)
No single metric tells the full story. See the BSP:MATD3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hospital Mater Dei SA is an integrated healthcare ecosystem that provides hospital and oncological services. The company provides a wide range of healthcare services, including hospitalizations, surgeries, oncology treatments, medical appointments, and diagnostic exams.
85GF Score
Get the complete analysis for BSP:MATD3
Debt-to-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BSP:MATD3 has been successfully added to your 
